{
  "url": "https://openlegislation.uk/eu-regulation-2005-869/annex/division-A/division-4/division-4.1/division-4.1.1",
  "json_url": "https://openlegislation.uk/eu-regulation-2005-869/annex/division-A/division-4/division-4.1/division-4.1.1.json",
  "legislation": "eur/2005/869",
  "legislation_title": "Commission Regulation (EC) No 869/2005 of 8 June 2005 amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin as regards ivermectin and carprofen (Text with EEA relevance)",
  "legislation_url": "https://openlegislation.uk/eu-regulation-2005-869",
  "path": "annex/division/A/division/4/division/4.1/division/4.1.1",
  "kind": "division",
  "number": "4.1.1",
  "heading": "Arylpropionic acid derivative",
  "text": "Pharmacologically active substance(s)\nMarker residue\nAnimal species\nMRLs\nTarget tissues\n‘Carprofen\nSum of carprofen and carprofen glucuronide conjugate\nBovine, equidae\n500 μg/kg\nMuscle\n1 000 μg/kg\nFat\n1 000 μg/kg\nLiver\n1 000 μg/kg\nKidney’",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eur/2005/869/annex/division/A/division/4/division/4.1/division/4.1.1",
    "retrieved_at": "2026-11-01T14:54:36.118406+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}